Retail Price Fixation of 65 new drug application

8205 GI/202 4 (1) EXTRAORDINARY PART II —Section 3 —Sub-section ( ii) PUBLISHED BY AUTHORITY No. 5085] NEW DELHI, THURSDAY , DEC EMBER 19, 2024 /AGRAHAYANA 28, 194 6 CG-DL-E-19122024-259536 (1) (2) (3) (4) (5) (6) MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals ) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, th e 19th December , 2024 S.O. 5493(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249 (E) dated 11th November , 2022 issued by the Governm ent of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the Table herein below as the retail price, exclusive of Goods an d Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE S. No. Medicines Strength Unit Manufacturer & Marketing Company Retail Price (in Rs.) (1) (2) (3) (4) (5) (6) 1 Acebrophylline and N-Acetylcysteine Tablets Each film coated tablet contains: Acebrophylline 100 mg N-Acetylcy steine Ph. Eur. 600 mg 1 Tablet M/s Win Medicare Pvt. Ltd./ M/s Modi - Mundipharma Pvt. Ltd. 14.31 2 Acyclovir Sustained - Release Tablets Each uncoated sustained -release tablet contains: Acyclovir IP 1200mg 1 Tablet M/s Rivpra Formulation Pvt. Ltd. / M/s M ankind Pharma Ltd. 56.21 3 Atorvastatin & Ezetimibe Tablet s Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg Ezetimibe IP 10 mg 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Sun Pharma Laboratories Limited 34.65 4 Atorvastatin & Ezetimibe Tablet s Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40 mg Ezetimibe IP 10 mg 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Sun Pharmaceutical Industries Limited 34.65 5 Atorvastatin & Ezetimibe Tablet s Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Ezetimibe IP 10 mg 1 Tablet M/s Sun Pharma Laboratories Limited/ M/s Sun Pharmaceutical Industries Limited 27.38 6 Atorvastatin & Ezetimibe Tablets Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Ezetimibe IP 10 mg 1 Tablet M/s Sun Pharma Laboratories Limited 27.38 7 Dispersible Amoxycillin & Potassium Clavulanate Tablets BP Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 400 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 57 mg 1 Tablet M/s Malik Lifesciences Pvt. Ltd./ M/s Micro Labs Ltd. 24.66 8 Bisoprolol Fumarate and Amlodipine tablets Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine besylate IP eq. to Amlodipine 5 mg 1 Tablet M/s Dr. Miltons Laboratories Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. 8.40 9 Bisoprolol Fumarate and Amlodipine tablets Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine besylate IP eq. to Amlodipine 5 mg 1 Tablet M/s Dr. Miltons Laboratories Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. 6.32 10 Cefuroxime Axetil and Potassium clavulan ate Tablets Each film coated tablet contain s: Cefuroxime Axetil IP eq. to Cefuroxime 500 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg 1 Tablet M/s Alps communication Pvt. Ltd./ M/s Aristo Laboratories Pvt. Ltd. 58.08 11 Cefuroxime Axetil & Potassium Clavulanate Tablets Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime 500mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg 1 Tablet M/s Innova Captab Limited /M /s Dr. Reddy's Laboratories Limited 58.08 12 Vitamin D3 Oral Drops Each ml con tains : Cholecalciferol ( Vitamin D3) IP 800 IU 1 ml M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Alkem Laboratories Ltd. 5.75 13 Cholecalciferol (Vitamin D3) oral solution Each 5 ml contains: Cholecalciferol IP (in nano droplet form) 60000IU 1 ml M/s Ravenb hel Healthcare Pvt. Ltd./ M/s Aristo Laboratories Pvt. Ltd. 18.93 14 Cholecalciferol (Vitamin D3) oral solution Each 5 ml contains: Cholecalciferol IP 60000IU 1ml M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Macleods Pharmaceuticals Ltd. 20.23 15 Cilnidipine & Metoprolol Succinate (ER) Tablets Each film coated bilayered tablet contains: Cilnidipine 10mg Metoprolol Succinate USP 23.75mg eq. to Metoprolol Tartrate 25mg (in extended -release form) 1 Tablet M/s Ravenbhel Biotech / M/s Mankind Pharma Ltd. 9.91 16 Cilnidipine & Metoprolol Succinate (ER) Tablets Each film coated bilayered tablet contains: Cilnidipine 10mg Metoprolol Succinate USP 47.5mg eq. to Metoprolol Tartrate 50mg (in extended release fo rm) 1 Tablet M/s Ravenbhel Biotech/ M/s Mankind Pharma Ltd . 11.02 17 Dextromethorphan Hydrobromide, Bilastine & Phenylephrine Hydrochloride Syrup Each 5ml contains: Dextromethorphan Hydrobromide IP 10mg Bilastine IP 3.3mg Phenylephrine Hydrochloride IP 5mg 1ml M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Akumentis Healthcare Ltd. 1.17 18 Diclofenac Injection IP Each ml contains : Diclofenac sodium IP 75 mg 1ml M/s Nitin Lifesciences Ltd /M/s Aristo Laboratories Pvt. Ltd. 31.38 19 Esomeprazole and Domperidone Sustained Release capsules Each hard gelatin capsule contains: Esomeprazole Magnesium IP eq. to Esomeprazole 40 mg (as enteric coated pellets) Domperidone Maleate IP eq. to Domperidone 30 mg (sustained release) 1 Capsule M/s Windlas Biotech Ltd./ M/s Intas Pharmaceuticals Ltd. 12.39 20 Esomeprazole & Domperidone Capsules Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40 mg (as enteric coated pellets) Domperidone IP 30 mg (as sustained release pellets) 1 Capsule M/s Pure & Cu re Healthcare Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 12.50 21 Etamsylate & Tranexamic Acid Tablets Each film coated tablet contains: Etamsylate BP 250 mg Tranexamic Acid IP 250 mg 1 Tablet M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Germ an Remedies Pharmaceuticals Pvt. Ltd. 19.59 22 Glimepiride IP , Voglibose IP, Metformin Hydrochloride (SR) tablets Each uncoated bilayered tablet contains: Glimepiride IP 0.5 mg, Voglibose IP 0.2 mg, Metformin Hydrochloride IP (as sustained release form) 500 mg 1 Tablet M/s Windlas Biotech Limited/ M/s Intas Pharmaceuticals Ltd. 9.12 23 Gliclazide MR & Metformin Hydrochloride ER tablets Each uncoated bilayered tablet contains: Metformin Hydrochloride (in extended release form) IP 500 mg Gliclazide (in m odified release form) IP 30 mg 1 Tablet M/s Unison Pharmaceuticals Pvt. Ltd 7.46 24 Gliclazide MR & Metformin Hydrochloride ER tablets Each uncoated bilayered tablet contains: Metformin Hydrochloride (in extended release form) IP 500 mg Gliclazide (in mo dified release form) IP 60 mg 1 Tablet M/s Unison Pharmaceuticals Pvt. Ltd 9.74 25 Glimepiride, Voglibose IP, Metformin Hydrochloride IP (as sustained release form) tablets Each uncoated bilayered tablet contains: Glimepiride IP 0.5mg Voglibose IP 0.2mg Metformin Hydrochloride IP 500mg (as sustained release form) 1 Tablet M/s Windlas Biotech Ltd./ M/s Lupin Limited 9.12 26 Glimepiride, Voglibose and Metformin Hydrochloride (ER) tablets Each uncoated bi-layered tablet contains: Glimepiride IP 1mg, Voglibo se IP 0.2mg and Metformin Hydrochloride IP 500mg (Extended - Release form) 1 Tablet M/s Mascot Health Series Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 11.62 27 Glimepiride, Voglibose and Metformin Hydrochloride (E R) tablets Each uncoated bi-layered tablets contains: Glimepiride IP 2 mg, Voglibose IP 0.2mg and Metformin Hydrochloride IP 500mg (Extended - Release form) 1 Tablet M/s Mascot Health Series Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 14.79 28 Itraconazole Capsules BP Each hard gelatin capsule contains: Itraconazole BP 50 mg 1 Capsule M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Biological E. Limited 11.51 29 Multivitamin & Multimineral Drops Each ml contains : Cholecalciferol (as Stabilized)IP 200 IU Pyridoxine HCl IP 0.5mg Niacinamide IP 5mg Cyanocobalamin IP 1mcg Sodium Selenite Pentahydrate BP eq. to elemental Selenium 10 mcg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 2 mg Manganese sulphate Monohydr ate BP eq. to elemental Manganese 3 mcg Sodium molybdate di hydrate BP eq. to elemental Molybdenum 1 mcg L-Lysine Hydrochloride IP 30 mg Potas sium Iodi de IP eq. to elemental Iodine 20 mcg Biotin IP 5 mcg Chromium Picolinate IP eq. to elemental Chromium 1 mc g Myo -Inositol IP 10 mg Beta Carotene Dispersion 2.5% 18 mg 1 ml M/s Orda in Health Care Global Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd. 3.10 30 Pantoprazole & Cinitapride SR capsules Each hard gelatin capsule contains: Pantoprazole Sodium IP eq. to Pantoprazole 40 mg (as enteric coated tablet) Cinitapr ide Hydrogen tartrate eq. to Cinitapride (as Sustained release tablet)3 mg 1 Capsule M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Dr . Reddy's Laboratories Ltd. 24.82 31 Paracetamol & Mefenamic Acid Suspension Each 5 ml contains: Paracetamol IP 250 mg Mefe namic Acid IP 100 mg 1 ml M/s Tirupati Medicare Ltd./ M/s Dr . Reddy's Laboratories Limited 0.92 32 Paracetamol and Mefenamic Acid Suspension Each 5 ml contains: Paracetamol IP 125 mg Mefenamic Acid IP 50 mg 1 ml M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 0.73 33 Paracetamol IP & Mefenamic Acid Suspension Each 5 ml contains: Paracetamol IP 125 mg Mefenamic Acid IP 50 mg 1 ml M/s Tirupati Medicare Limited / M/s Dr. Reddy's Laboratories Limited 0.73 34 Riboflavin, Folic Acid Niacinamide & Lactic Acid Bacillus Spores Tablets Each uncoated tablet contains: Riboflavin IP 10mg Folic Acid IP 1.5mg Niacinamide IP 100mg Lactic Acid Bacillus Spores 60 million 1 Tablet M/s Marine Medicare Pvt. L td. / M/s Nicholas Healthcare Limited 4.25 35 Sodium Alginate, Sodium Bicarbonate, Calcium Carbonate Oral Suspension Each 5 ml contains: Sodium Alginate IP 250 mg Sodium Bicarbonate IP 133.5 mg Calcium Carbonate IP 80 mg 1 ml M/s Windlas Biotech Ltd./ M/s Biological E. Ltd. 0.83 36 Tacrolimus Ointment Composition: Tacrolimus I.P. eq. to Anhydrous Tacrolimus 0.1%w/w 1 gm M/s Rivpra Formulation Pvt. Ltd./ M/s RPG Life Sciences Ltd. 35.64 37 Telmisartan & Chlorthalidone Tablets Each uncoated tablet conta ins: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg 1 Tablet M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 11.59 38 Telmisartan & Cilnidipine Tablets Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipin e IP 10 mg 1 Tablet M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 11.11 39 Telmisartan & Cilnidipine Tablets Each film coated bilayered tablet contains: Telmisartan IP 80 mg Cilnidipine IP 10 mg 1 Tablet M/s Macleods Pharmaceuticals Ltd. 16.10 40 Telmisartan & Indapamide tablets Each uncoated bilayered tablet contains: Telmisartan IP 40mg Indapamide IP 1.5mg ( as sustained release) 1 Tablet M/s Windlas Biotech Ltd. / M/s Eris Lifesciences Limited 13.25 41 Telmisarta n, Cilnidipine and Chlorthalidone tablets Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Chlorthalidone IP 12.50 mg 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. 15.15 42 Telmisartan, Amlodipine and Hydrochlorothiazide Tablets Each film coated tablet contains: Telmisartan IP 40 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg Hydrochlorothia zide IP 12.5 mg 1 Tablet M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. 11.00 43 Tranexamic Acid and Mefenamic Acid tablets Each film coated tablet contains: Tranexamic Acid I P 500 mg Mefenamic Acid IP 250 mg 1 Tabl et M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Pharmed Limited 31.50 44 Dapagliflozin, Glimepiride, Metformin Hydrochloride (extended release) tablets Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 1 mg, Metformin Hydrochloride (extended release) IP 500 mg 1 Tablet M/s Mascot Health Series Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. 12.42 45 Dapagliflozin, Glimepiride, Metformin Hydrochloride (extended release) tablets Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 2 mg, Metformin Hydrochloride IP 500 mg (extended release) 1 Tablet M/s Mascot Health Series Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. 12.42 46 Dapagliflozin, Glimepiride, Metformin Hydrochloride (extended release) tablets Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Glimepiride IP 1 mg, Metformin Hydrochloride (extended release) IP 500 mg 1 Tablet M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd. 12.42 47 Dapagliflozin, Glimepiride, Metformin Hydrochloride (extended release) tablets Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapa gliflozin 10 mg, Glimepiride IP 2 mg, Metformin Hydrochloride (extended release) IP 500 mg 1 Tablet M/s Mascot Health Series Pvt. Ltd./ M/s Alembic Pharmaceuticals Ltd. 12.42 48 Sitagliptin, Dapagliflozin and Metformin Hydrochloride (extended release) Tablets Each film coated bilayered tablet contains: Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100mg Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metformin hydrochloride IP ( as extended release form) 1000mg 1 Tablet M/s Mascot Hea lth Series Pvt. Ltd/ M/s FDC limited 18.21 49 Sitagliptin, Dapagliflozin and Metformin Hydrochloride (extended release) Tablets Each film coated bilayered tablet contains: Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100mg Dapagliflozin prop anediol USP eq. to dapagliflozin 10mg Metformin hydrochloride IP ( as extended release form) 500mg 1 Tablet M/s Mascot Health Series Pvt. Ltd/ M/s FDC Limited 17.26 50 Sitagliptin, Pioglitazone and Metformin Hydrochloride (sustained release) Tablets Each film coated bilayered tablet contains: Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin hydrochloride IP ( as sustained release form) 500mg 1 Tablet M/s Akums Drugs & Pharma ceuticals Ltd./ M/s Cadila Pharmaceuticals Ltd. 14.15 51 Sitagliptin, Pioglitazone and Metformin Hydrochloride (sustained release) Tablets Each film coated bilayered tablet contain s: Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100mg Pioglita zone Hydrochloride IP eq. to Pioglitazone 15mg Metformin hydrochloride IP ( as sustained release form) 1000mg 1 Tablet M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Cadila Pharmaceuticals Ltd. 15.43 52 Sitagliptin & Metformin Hydrochloride tablets Each fi lm coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Metformin Hydrochloride IP 500 mg 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd. 9.00 53 Sitagliptin & Metformin Hydrochlorid e tablets Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Metformin Hydrochloride IP 1000 mg 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd. 9.87 54 Vildagliptin (SR) & Metformin Hydrochloride (SR) tablets Each film coated bilayered tablet contains: Vildagliptin IP 100 mg (as sustained release form) Metformin Hydrochloride IP 500 mg (as sustained release form) 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Prim us Remedies Pvt. Ltd. 10.24 55 Vildagliptin (SR) & Metformin Hydrochloride (SR) tablets Each film coated bilayered tablet contains: Vildagliptin IP 100 mg (as sustained release form) Metformin Hydrochloride IP 1000 mg (as sustained release form) 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd. 11.55 56 Linagliptin & Metformin Hydrochloride (ER) tablets Each film coated bilayered tablet contains: Linagliptin 5 mg Metformin hydrochloride IP (as extended release form) 500 mg 1 Tablet M/s Mascot Health Series Pvt. Ltd. /M/s Eris Lifesciences Limited 10.68 57 Ceftazidime and Avibactam Powder for concentrate Solution for Infusion Each vial contains: Sterile Ceftazidime Pentahydrate IP eq. to Anhydrous Ceftazidime 2 gm Sterile Avibactam sodium eq. to Avibactam 0.5 gm 1 vial M/s GMH Organics/ M/s Aurobindo Pharma Limited 1422.21 58 Ceftriaxone, Disodium Edetate and Sulbactam Powder for Solution for Infusion Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 1000mg Sulbactam Sodium IP eq. to Sulbactam 500mg Disodium Edetate IP 37mg 1 vial M/s Alkem Health Science (A Unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd 515.57 59 Ceftriaxone, Disodium Edetate and Sulbactam Powder for Solution for Infusion Each v ial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 2000mg Sulbactam Sodium IP eq. to Sulbactam 1000mg Disodium Edetate IP 74mg 1 vial M/s Al kem Health Science (A Unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd 1036.60 60 Empagliflozin & Metformin Hydrochloride Tablets Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg 1 Tablet M/s Cipla Ltd. 8.50 61 Empagliflozin & Metformin Hydrochloride Tablets Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg 1 Tablet M/s Cipla Ltd. 12.00 62 Ferrous Bis- glycinate, Folic Acid, Zinc Bis -glycinate & Vitamin B12 (Cyanocobalamin) Tablets Each film coated tablet contains: Ferrous Bis -glycinate eq. to Elemental Iron 60mg Zinc Bis -glycinate eq. to Elemental Zinc 15mg Folic Acid IP 1mg Vitamin B12 IP 15mcg (Cyanocobalamin) 1 Tablet M/s Windlas Biotech Limited / M/s Biological E. Limited 8.17 63 Iron tonic with Vitamin B12 and Folic Acid Each 5ml contains: Ferric Ammonium Citrate IP 80mg Folic Acid IP 0.166mg Vitamin B12 IP 1mcg 1 ml M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd. 0.45 64 Atorvastatin and Ezetimibe tablets Each film coated tablet contains: Atorvastatin Calcium IP equivalent to Atorvasta tin 80 mg, Ezetimibe IP 10mg 1 Tablet M/s Windlas Biotech ltd./ M/s Intas pharmaceuticals Ltd. 50.00 65 Famotidine, Calcium Carbonate & Magnesium Hydroxide Chewable Tablets Each chewable tablet contains: Famotidine IP 10mg Calcium Carbonate IP 800mg Magne sium Hydroxide IP 165mg 1 Tablet M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Akumentis Healthcare Ltd. 5.30 Note s: (a) The manufacturer of above -mentioned formulations i.e., “new drug” under paragraph 2 (1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price fo r a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall iss ue a price list in Form –V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As pe r para 24(4) of DPCO 2013, every retailer and dealer shall display price list and t he supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily acce ssible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / market er as mentioned above i.e. who have applied for the same by submitting Form -I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory r equirements as laid down by the Govt. under relevant statute s/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer /marketing companie s. (f) In case the retail price of any of the aforesaid formula tions is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount a long with the interest thereon under the provisions of the D PCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufactur er & Marketing Companies specified in the corresp onding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufactur er & Marketing Companies as specified in corres ponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded. [PN/260/127/2024/F /F. No. 8(128)/2024/D.P./NPPA -Div.-II] MAHAVEER SAINI , Dy. Director Uploaded by Dte. of Printing at Government of In dia Press, Ring R oad, Mayapuri, New Delhi -110064 and Published by the Controller of Publications, Delhi -110054.